or Try an Advanced Search...

    Technical Analysis for COR - Cencora, Inc.

    Grade Last Price % Change Price Change
    C 237.95 0.11% 0.26
    COR closed up 0.11 percent on Wednesday, April 24, 2024, on 81 percent of normal volume. It ran into resistance at its 50 day moving average.
    Earnings due: Apr 30
    *** please verify all earnings dates ***
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Flat Flat
    Historical COR trend table...
    Date Alert Name Type % Chg
    50 DMA Resistance Bearish 0.00%
    Outside Day Range Expansion 0.00%
    50 DMA Resistance Bearish 0.11%
    NR7 Range Contraction 0.11%
    Inside Day Range Contraction 0.11%
    Fell Below 50 DMA Bearish 0.46%
    Gapped Down Weakness 0.46%
    Crossed Above 50 DMA Bullish -0.49%
    Gapped Up Strength -0.49%
    Fell Below 50 DMA Bearish 0.27%
    Older End-of-Day Signals for COR ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 18 hours ago
    Outside Day about 18 hours ago
    Rose Above 50 DMA about 20 hours ago
    Reversed from Down about 20 hours ago
    60 Minute Opening Range Breakout about 20 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    COR Chart by TradingView
    Basic chart:

    Profile

    Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Our 46,000+ worldwide team members contribute to positive health outcomes through the power of our purpose: We are united in our responsibility to create healthier futures. Cencora is ranked #11 on the Fortune 500 and #24 on the Global Fortune 500 with more than $200 billion in annual revenue.
    Classification
    Sector: Healthcare
    Industry: Medical Distribution
    Keywords: Pharmaceutical Healthcare Products

    Is COR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 0 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 16 If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,700 Today
    Apr 15 Is Artivion (AORT) Outperforming Other Medical Stocks This Year?
    Apr 11 Boston Scientific (BSX) Faces Rising Costs, Competition
    Apr 5 Cencora Announces Date and Time for Second Quarter Fiscal 2024 Earnings Release
    Mar 29 Here's Why Cencora (COR) is a Strong Value Stock
    Mar 28 Are Medical Stocks Lagging Artivion (AORT) This Year?
    Mar 27 Why Cencora (COR) is a Top Growth Stock for the Long-Term
    Mar 25 Cencora Remains Chronically Undervalued, With Material Growth Potential
    Mar 12 Cencora announces CEO retirement
    Mar 12 Cencora Announces Leadership Succession Plan
    See more COR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 246.75
    52 Week Low 162.1724
    Average Volume 1,149,811
    200-Day Moving Average 205.93
    50-Day Moving Average 238.00
    20-Day Moving Average 239.56
    10-Day Moving Average 236.97
    Average True Range 3.30
    RSI (14) 48.98
    ADX 21.22
    +DI 13.22
    -DI 21.88
    Chandelier Exit (Long, 3 ATRs) 236.86
    Chandelier Exit (Short, 3 ATRs) 242.98
    Upper Bollinger Bands 246.21
    Lower Bollinger Band 232.91
    Percent B (%b) 0.38
    BandWidth 5.55
    MACD Line -0.26
    MACD Signal Line 0.10
    MACD Histogram -0.36
    Fundamentals Value
    Market Cap 47.79 Billion
    Num Shares 201 Million
    EPS 8.20
    Price-to-Earnings (P/E) Ratio 29.02
    Price-to-Sales 0.00
    Price-to-Book 0.00
    PEG Ratio 1.58
    Dividend 1.92
    Dividend Yield 0.81%
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 242.38
    Resistance 3 (R3) 242.16 240.48 241.64
    Resistance 2 (R2) 240.48 239.35 240.58 241.39
    Resistance 1 (R1) 239.21 238.65 239.85 239.43 241.15
    Pivot Point 237.53 237.53 237.84 237.63 237.53
    Support 1 (S1) 236.26 236.40 236.90 236.48 234.75
    Support 2 (S2) 234.58 235.70 234.68 234.51
    Support 3 (S3) 233.31 234.58 234.26
    Support 4 (S4) 233.53